Nathaniel Jones — York Research Database

Emailnathaniel.jonesyork.acuk

16 Article

Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery
Russell, C., Carter, J., Borgia, J. M., Bush, J., Calderón, F., Gabarró, R., Conway, S., Mottram, J. C., Wilkinson, A. J. & Jones, N., 31 Oct 2023, (E-pub ahead of print) In: ACS Infectious Diseases. 18 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Bromodomain factor 5 is an essential regulator of transcription in Leishmania
Jones, N. G., Geoghegan, V., Moore, G., Carnielli, J. B. T., Newling, K., Calderón, F., Gabarró, R., Martín, J., Prinjha, R. K., Rioja, I., Wilkinson, A. J. & Mottram, J. C., 13 Jul 2022, In: Nature Communications. 13, 1, 18 p., 4071.
Research output: Contribution to journal › Article › peer-review

Open Access
File
CLK1/CLK2 driven signalling at the Leishmania kinetochore is captured by spatially referenced proximity phosphoproteomics
Geoghegan, V., Carnielli, J. B. T., Jones, N., Saldivia, M., Antoniou, S., Hughes, C., Neish, R., Dowle, A. & Mottram, J. C., 28 Nov 2022, In: Communications Biology.
Research output: Contribution to journal › Article › peer-review

Open Access
File

Expression of full length Leishmania BDF proteins using the Hypertrans® system to support structural biology and drug discovery.
Jones, N.
MEDICAL RESEARCH COUNCIL (MRC)
1/12/19 → 31/07/22
Project: Research project (funded) › Research